SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-054498
Filing Date
2020-11-18
Accepted
2020-11-18 17:05:02
Documents
12
Period of Report
2020-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K cnst-8k_20201113.htm   iXBRL 8-K 42454
  Complete submission text file 0001564590-20-054498.txt   176174

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cnst-20201113.xsd EX-101.SCH 5820
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20201113_lab.xml EX-101.LAB 20227
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20201113_pre.xml EX-101.PRE 12117
5 EXTRACTED XBRL INSTANCE DOCUMENT cnst-8k_20201113_htm.xml XML 3695
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38584 | Film No.: 201325856
SIC: 2834 Pharmaceutical Preparations